These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23932664)

  • 41. Psychosocial functioning in first-episode psychosis and associations with neurocognition, social cognition, psychotic and affective symptoms.
    Stouten LH; Veling W; Laan W; van der Helm M; van der Gaag M
    Early Interv Psychiatry; 2017 Feb; 11(1):23-36. PubMed ID: 25585960
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lack of insight 3 years after first-episode psychosis: an unchangeable illness trait determined from first presentation?
    Ayesa-Arriola R; Moríñigo JD; David AS; Pérez-Iglesias R; Rodríguez-Sánchez JM; Crespo-Facorro B
    Schizophr Res; 2014 Aug; 157(1-3):271-7. PubMed ID: 24934905
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prodromal symptoms and remission following first episode psychosis.
    Renwick L; Lyne J; Donoghue BO; Owens L; Doyle R; Hill M; McCarthy E; Pilling M; O'Callaghan E; Clarke M
    Schizophr Res; 2015 Oct; 168(1-2):30-6. PubMed ID: 26187148
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prediction of functional remission in first-episode psychosis: 12-month follow-up of the randomized-controlled trial on extended early intervention in Hong Kong.
    Chang WC; Kwong VW; Chan GH; Jim OT; Lau ES; Hui CL; Chan SK; Lee EH; Chen EY
    Schizophr Res; 2016 May; 173(1-2):79-83. PubMed ID: 27017490
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 20-year trajectories of positive and negative symptoms after the first psychotic episode in patients with schizophrenia spectrum disorder: results from the OPUS study.
    Starzer M; Hansen HG; Hjorthøj C; Albert N; Nordentoft M; Madsen T
    World Psychiatry; 2023 Oct; 22(3):424-432. PubMed ID: 37713547
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predicting first-episode psychosis patients who will never relapse over 10 years.
    Hui CL; Honer WG; Lee EH; Chang WC; Chan SK; Chen ES; Pang EP; Lui SS; Chung DW; Yeung WS; Ng RM; Lo WT; Jones PB; Sham P; Chen EY
    Psychol Med; 2019 Oct; 49(13):2206-2214. PubMed ID: 30375301
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Patterns of recovery course in early intervention for FIRST episode non-affective psychosis patients: The role of timing.
    Ayesa-Arriola R; Pelayo Terán JM; Setién-Suero E; Neergaard K; Ochoa S; Ramírez-Bonilla M; Pérez-Iglesias R; Crespo-Facorro B
    Schizophr Res; 2019 Jul; 209():245-254. PubMed ID: 30772066
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuropsychological, clinical and cognitive insight predictors of outcome in a first episode psychosis study.
    O'Connor JA; Wiffen B; Diforti M; Ferraro L; Joseph C; Kolliakou A; Bonaccorso S; Murray RM; David AS
    Schizophr Res; 2013 Sep; 149(1-3):70-6. PubMed ID: 23815972
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Specialised first-episode psychosis services: a systematic review of the literature].
    Skalli L; Nicole L
    Encephale; 2011 May; 37 Suppl 1():S66-76. PubMed ID: 21600336
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Suicide attempt in first-episode psychosis: a 7.4 year follow-up study.
    Robinson J; Harris MG; Harrigan SM; Henry LP; Farrelly S; Prosser A; Schwartz O; Jackson H; McGorry PD
    Schizophr Res; 2010 Jan; 116(1):1-8. PubMed ID: 19864115
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Subclinical depressive symptoms and continued cannabis use: predictors of negative outcomes in first episode psychosis.
    González-Ortega I; Alberich S; Echeburúa E; Aizpuru F; Millán E; Vieta E; Matute C; González-Pinto A
    PLoS One; 2015; 10(4):e0123707. PubMed ID: 25875862
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metacognitive functioning predicts positive and negative symptoms over 12 months in first episode psychosis.
    McLeod HJ; Gumley AI; Macbeth A; Schwannauer M; Lysaker PH
    J Psychiatr Res; 2014 Jul; 54():109-15. PubMed ID: 24725651
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Duration of untreated psychosis predicts functional and clinical outcome in children and adolescents with first-episode psychosis: a 2-year longitudinal study.
    Fraguas D; Del Rey-Mejías A; Moreno C; Castro-Fornieles J; Graell M; Otero S; Gonzalez-Pinto A; Moreno D; Baeza I; Martínez-Cengotitabengoa M; Arango C; Parellada M
    Schizophr Res; 2014 Jan; 152(1):130-8. PubMed ID: 24332406
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Demographic and clinical correlates of substance use disorders in first episode psychosis.
    Brunette MF; Mueser KT; Babbin S; Meyer-Kalos P; Rosenheck R; Correll CU; Cather C; Robinson DG; Schooler NR; Penn DL; Addington J; Estroff SE; Gottlieb J; Glynn SM; Marcy P; Robinson J; Kane JM
    Schizophr Res; 2018 Apr; 194():4-12. PubMed ID: 28697856
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development and validation of multivariable prediction models of remission, recovery, and quality of life outcomes in people with first episode psychosis: a machine learning approach.
    Leighton SP; Upthegrove R; Krishnadas R; Benros ME; Broome MR; Gkoutos GV; Liddle PF; Singh SP; Everard L; Jones PB; Fowler D; Sharma V; Freemantle N; Christensen RHB; Albert N; Nordentoft M; Schwannauer M; Cavanagh J; Gumley AI; Birchwood M; Mallikarjun PK
    Lancet Digit Health; 2019 Oct; 1(6):e261-e270. PubMed ID: 33323250
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Persistent Negative Symptoms in First-Episode Psychosis: Early Cognitive and Social Functioning Correlates and Differences Between Early and Adult Onset.
    Puig O; Baeza I; de la Serna E; Cabrera B; Mezquida G; Bioque M; Lobo A; González-Pinto A; Parellada M; Corripio I; Vieta E; Bobes J; Usall J; Contreras F; Cuesta MJ; Bernardo M; Castro-Fornieles J;
    J Clin Psychiatry; 2017; 78(9):1414-1422. PubMed ID: 28922588
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Duration of active psychosis and functional outcomes in first-episode non-affective psychosis.
    Pelayo-Terán JM; Gajardo-Galán V; Gómez-Revuelta M; Ortiz-García de la Foz V; Ayesa-Arriola R; Tabarés-Seisdedos R; Crespo-Facorro B
    Eur Psychiatry; 2018 Aug; 52():29-37. PubMed ID: 29614389
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Change in cannabis use, clinical symptoms and social functioning among patients with first-episode psychosis: a 5-year follow-up study of patients in the OPUS trial.
    Clausen L; Hjorthøj CR; Thorup A; Jeppesen P; Petersen L; Bertelsen M; Nordentoft M
    Psychol Med; 2014 Jan; 44(1):117-26. PubMed ID: 23590927
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gender differences in first-episode psychosis at 5-year follow-up--two different courses of disease? Results from the OPUS study at 5-year follow-up.
    Thorup A; Albert N; Bertelsen M; Petersen L; Jeppesen P; Le Quack P; Krarup G; Jørgensen P; Nordentoft M
    Eur Psychiatry; 2014 Jan; 29(1):44-51. PubMed ID: 23394824
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Longitudinal Cognitive Changes in Young Individuals at Ultrahigh Risk for Psychosis.
    Lam M; Lee J; Rapisarda A; See YM; Yang Z; Lee SA; Abdul-Rashid NA; Kraus M; Subramaniam M; Chong SA; Keefe RSE
    JAMA Psychiatry; 2018 Sep; 75(9):929-939. PubMed ID: 30046827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.